JPRN-UMIN000020710已完成未知
Effects of Canagliflozin on microbiota and glycometabolism, kidney function of patients with diabetic nephropathy - Effects of Canagliflozin on patients with diabetic nephropathy
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 33
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.patiens whose eGFR declined more than 25% during the observation period 2.patients with fasting blood glucose higher than 250mg/dl 3.patients who has been on dialysis or who went through renal transplantation 4.patients with type 1 diabetes or secondary diabetes 5.patients who has taken other investigational drugs within 3months of the beginning of this study 6.patients who fall under contraindication of Canagliflozin 7.patients whom the doctor decided unsuitable for the study
研究者
相似试验
已完成
不适用
Effects of canagliflozin on the glycemic control and plasma GLP-1 levels.Type 2 diabetes mellitusJPRN-UMIN000018345akakinen clinic45
已完成
不适用
Study of the beneficial effect of Canagliflozin on nocturnal home BP in Japanese T2DM patients(SHIFT-J STUDY)Type 2 diabetes mellitus patients with hypertensionJPRN-UMIN000023487Jichi Medical University School of Medicine100
招募中
不适用
Effect of Canagliflozin in Non-diabetic overweight and obesity Patients with albuminuria: A Randomized, Double-blind, Placebo-controlled TrialEffect of Canagliflozin in Non-diabetic overweight and obesity Patients.Canagliflozin and Non-diabetic overweight and obesity PatientsTCTR20190203003Rachadaphiseksompot Endorsement Fund80
尚未招募
不适用
Canagliflozin in non diabetic proteinuric diseaseCTRI/2020/09/027679COMMAND HOSPITAL AIR FORCE BANGALORE
已完成
4 期
A clinical trial to compare the effects of Canagliflozin and Sitagliptin in Patients with Type 2 Diabetes mellitus on a background metformin therapy.CTRI/2019/02/017435SRM College of Pharmacy40